Pharmacological and psychosocial treatments for adolescents with ADHD: An updated systematic review of the literature

Clinical Psychology Review

Volumn 34, Issue 3, 2014, Pages 218-232

  Sibley, Margaret H ^a   Kuriyan, Aparajita B ^a   Evans, Steven W ^b   Waxmonsky, James G ^c   Smith, Bradley H ^d  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b OHIO UNIVERSITY   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d UNIVERSITY OF HOUSTON   (United States)

Author keywords

ADHD; Adolescence; Behavior therapy; Stimulant medication

Indexed keywords

ADOLESCENCE; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; COGNITIVE ENHANCEMENT TRAINING; COMORBIDITY; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG INDUSTRY; EFFECT SIZE; FUNDING; HUMAN; NEUROFEEDBACK; PHARMACEUTICAL CARE; PRACTICE GUIDELINE; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; REVIEW; STUDY DESIGN; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT OUTCOME; WORKING MEMORY; ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; MULTIMODALITY CANCER THERAPY; PSYCHOLOGY;

ATOMOXETINE; CENTRAL STIMULANT AGENT; METHYLPHENIDATE; PROPYLAMINE;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR THERAPY; CENTRAL NERVOUS SYSTEM STIMULANTS; COMBINED MODALITY THERAPY; HUMANS; METHYLPHENIDATE; PROPYLAMINES; TREATMENT OUTCOME;

EID: 84895985097     PISSN: 02727358     EISSN: 18737811     Source Type: Journal    
DOI: 10.1016/j.cpr.2014.02.001     Document Type: Review

References (113)

1. American Academy of Child & Adolescent Psychiatry Practice parameter for the assessment and treatment of children and adolescents with Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2007, 46:894-921.
2. American Academy of Pediatrics ADHD: Clinical practice guidelines for diagnosis, evaluation, and treatment of attention deficit/hyperactivity disorder in children and adolescents. Pediatrics 2011, 128:1-16.
3. American Association of School Adiministrators Weathering the storm: How the economic recession continues to impact school districts 2012, March, American Association of School Administrators, (Retrieved August 2013, from http://www.aasa.org).
4. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2013, Author, Washington, DC. 5th ed.
5. Antshel K.M., Faraone S.V., Gordon M. Cognitive behavioral treatment outcomes in adolescent ADHD. Journal of Attention Disorders 2014, (in press).
6. Bagwell C., Molina B.S.G., Pelham W.E., Hoza B. Attention-Deficit Hyperactivity Disorder and problems in peer relations: Predictions from childhood to adolescence. Journal of the American Academy of Child and Adolescent Psychiatry 2001, 40:1285-1292.
7. Barkley R.A. Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychological Bulletin 1997, 121:65.
8. Barkley R. Adolescents with attention-deficit/hyperactivity disorder: An overview of empirically based treatments. Journal of Psychiatric Practice 2004, 10:39-56.
9. Barkley R.A. Attention-Deficit Hyperactivity Disorder: A handbook for diagnosis and treatment 2006, Guilford, New York. 3rd ed.
10. Barkley R., Anderson D., Kruesi M. A pilot study of the effects of atomoxetine on driving performance in adults with ADHD. Journal of Attention Disorders 2007, 10:306-316.
11. Barkley R., Edwards G., Laneri M., Fletcher K., Metevia L. The efficacy of problem-solving communication training alone, behavior management training alone, and their combination for parent-adolescent conflict in teenagers with ADHD and ODD. Journal of Consulting and Clinical Psychology 2001, 69:926-941.
12. Barkley R.A., Murphy K.R., Fischer M. ADHD in Adults: What the science says 2008, Guilford, New York.
13. Barkley R.A., Murphy K.R., O'Connell T., Connor D.F. Effects of two doses of methylphenidate on simulator driving performance in adults with attention deficit hyperactivity disorder. Journal of Safety Research 2005, 36:121-131.
14. Biederman J., Krishnan S., Zhang Y., McGough J.J., Findling R.L. Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. Clinical Therapeutics 2007, 29:450-463.
15. Biederman J., Lopez F.A., Boellner S.W., Chandler M.C. A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder. Pediatrics 2002, 110:258-266.
16. Biederman J., Melmed R., Patel A., McBurnett K., Konow J., Lyne A., et al. A randomized double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with Attention-Deficit/Hyperactivity Disorder. Pediatrics 2008, 121:e73-e84.
17. Bird H., Gould M., Staghezza B. Aggregating data from multiple informants in child psychiatry epidemiological research. Journal of the American Academy of Child and Adolescent Psychiatry 1992, 31:78-85.
18. Biswas A., Gnagy E., Molina B., Pelham W. Examining the decline of treatment usage in adolescents with Attention Deficit Hyperactivity Disorder. Poster presented at the annual meeting of the Association for Behavioral and Cognitive Therapies, New York, NY 2009.
19. Bostic J., Biederman J., Spencer T.J., Wilens T., Prince J., Monuteaux M.C., et al. Pemoline treatment of adolescents with Attention Deficit/Hyperactivity Disorder: A short-term controlled trial. Journal of Child & Adolescent Psychopharmacology 2000, 10:205-216.
20. Bullington P., Pawola L., walker R., Valenta A., Briars L., John E. Identification of medication non-adherence factors in adolescent transplant patients: The patient's viewpoint. Pediatric Transplantation 2007, 11:914-921.
21. Charach A., Yeung E., Climans T., Lillie E. Childhood attention-deficit/hyperactivity disorder and future substance use disorders: Comparative meta-analyses. Journal of the American Academy of Child and Adolescent Psychiatry 2011, 50:9-21.
22. Chronis A.M., Chacko A., Fabiano G.A., Wymbs B., Pelham W.E. Enhancements to the behavioral parent training paradigm for families of children with ADHD: Review and future directions. Clinical Child and Family Psychology Review 2004, 7:1-27.
23. Cohen J. Things I have learned (so far). American Psychologist 1990, 45(12):1304.
24. Conners C.K., Epstein J.N., March J.S., Angold A., Wells K.C., Klaric J., et al. Multimodal treatment of ADHD in the MTA: An alternative outcome analysis. Journal of the American Academy of Child & Adolescent Psychiatry 2001, 40:159-167.
25. Cox D.J., Davis M., Mikami A., Singh H., Merkel R.L., Burket R. Long-Acting methylphenidate reduces collision rates of young adult drivers with Attention-Deficit/Hyperactivity Disorder. Journal of Clinical Psychopharmacology 2012, 32:225-230.
26. Cox D.J., Merkel R.L., Moore M., Thorndike F., Muller C., Kovatchev B. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with Attention-Deficit/Hyperactivity Disorder. Pediatrics 2006, 118:e704-e710.
27. Cox D.J., Moore M., Burket R., Merkel R.L., Mikami A.Y., Kovatchev B. Rebound effects with long-acting amphetamine or methylphenidate stimulant medication preparations among adolescent male drivers with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 2008, 18:1-10.
28. De Los Reyes A., Kazdin A.E. Conceptualizing changes in behavior in intervention research: The range of possible changes model. Psychological Review 2006, 113:554.
29. Drechsler R., Rizzo P., Steinhausen H.C. Decision-making on an explicit risk-taking task in preadolescents with Attention-Deficit/Hyperactivity Disorder. Journal of Neural Transmission 2008, 115:201-209.
30. DuPaul G.J., Power T.J., Anastopoulos A.D., Reid R. ADHD Rating Scale-IV: Checklists, norms, and clinical interpretation 1998, Guilford Press.
31. DuPaul G.J., Weyandt L.L. School-based interventions for children and adolescents with Attention-Deficit/Hyperactivity Disorder: Enhancing academic and behavioral outcomes. Education & Treatment of Children 2006, 29:341-358.
32. Eccles J. Schools, academic motivation, and stage-environment fit. Handbook of Adolescent Psychology 2004, John Wiley & Sons, Inc., Hoboken, NJ. 2nd ed. R. Lerner, L. Steinberg (Eds.).
33. Edwards G., Barkley R., Laneri M., Fletcher K., Metevia L. Parent-adolescent conflict in teenagers with ADHD and ODD. Journal of Abnormal Child Psychology 2001, 29:557-572.
34. Evans S., Allen J., Moore S., Strauss V. Measuring symptoms and functioning of youth with ADHD in middle schools. Journal of Abnormal Child Psychology 2005, 33:695-706.
35. Evans S.W., Brady C.E., Harrison J.R., Bunford N., Kern L., State T., et al. Measuring ADHD and ODD symptoms and impairment using high school teachers' ratings. Journal of Clinical Child & Adolescent Psychology 2013, 42:197-207.
36. Evans S.W., Owens J.S., Bunford N. Evidence-based psychosocial treatments for children and adolescents with Attention-Deficit/Hyperactivity Disorder. Journal of Clinical Child and Adolescent Psychology 2014, (in press).
37. Evans S., Pelham W., Smith B., Bukstein O., Gnagy E., Greiner A., et al. Dose-response effects of methylphenidate on ecologically valid measures of academic performance and classroom behavior in adolescents with ADHD. Experimental and Clinical Psychopharmacology 2001, 9:163-175.
38. Evans S.W., Schultz B.K., DeMars C.E., Davis H. Effectiveness of the challenging horizons after-school program for young adolescents with ADHD. Behavior Therapy 2011, 42:462-474.
39. Evans S.W., Serpell Z.N., Schultz B.K., Pastor D.A. Cumulative benefits of secondary school-based treatment of students with attention deficit hyperactivity disorder. School Psychology Review 2007, 36:256-273.
40. Evans S.W., Sibley M.H., Serpell Z.N. Changes in caregiver strain over time in young adolescents with ADHD. Journal of Attention Disorders 2009, 12:516-524.
41. Fabiano G.A., Hulme K., Linke S., Nelson-Tuttle C., Pariseau M., Gangloff B., et al. The Supporting a Teen's Effective Entry to the Roadway (STEER) program: Feasibility and preliminary support for a psychosocial intervention for teenage drivers with ADHD. Cognitive and Behavioral Practice 2011, 18:267-280.
42. Fabiano G.A., Pelham W.E., Pisecco S., Evans S.W., Manos M.J., Caserta D., et al. A nationally representative survey of classroom-based, behavior modification treatment for ADHD. Poster presented at the Association for the Advancement of Behavior Therapy Conference, Reno, NV 2002, November.
43. Findling R., Childress A., Cutler A., Gasior M., Hamdani M., Ferreira C., et al. Efficacy and safety of lisdexamfetamine dimesylate in adolescents with Attention Deficit/Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2011, 50:395-405.
44. Findling R.L., Turnbow J., Burnside J., Melmed R., Civil R., Li Y. A randomized, double-blind, multicenter, parallel-group, placebo-controlled, dose-optimization study of the methylphenidate transdermal system for the treatment of ADHD in adolescents. CNS Spectrum 2010, 15:419-430.
45. Fischer M., Barkley R., Fletcher K., Smallish L. The stability of dimensions of behavior in ADHD and normal children over an 8-year follow-up. Journal of Abnormal Child Psychology 1993, 21:315-337.
46. Flay B.R., Biglan A., Boruch R.F., Castro F.G., Gottfredson D., Kellam S., et al. Standards of evidence: Criteria for efficacy, effectiveness and dissemination. Prevention Science 2005, 6:151-175.
47. Gevensleben H., Holl B., Albrecht B., Vogel C., Schlamp D., Kratz O., et al. Is neurofeedback an efficacious treatment for ADHD? A randomised controlled clinical trial. Journal of Child Psychology and Psychiatry 2009, 50:780-789.
48. Gray S.A., Chaban P., Martinussen R., Goldberg R., Gotlieb H., Kronitz R., et al. Effects of a computerized working memory training program on working memory, attention, and academics in adolescents with severe LD and comorbid ADHD: A randomized controlled trial. Journal of Child Psychology and Psychiatry 2012, 53:1277-1284.
49. Greenhill L., Pliszka S., Dulcan M., Bernet W., Arnold V., Beitchman J., et al. American academy of child and adolescent psychiatry. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. Journal of the American Academy of Child and Adolescent Psychiatry 2002, 41:26S-49S.
50. Greenhill L., Swanson J., Vitiello B., Davies M., Clevenger W., Wu M., et al. Impairment and deportment responses to different methylphenidate doses in children with ADHD: The MTA titration trial. Journal of the American Academy of Child and Adolescent Psychiatry 2001, 40(2):180-187.
51. Hannon B., McNaughton-Cassill M. SAT performance: Understanding the contributions of cognitive/learning and social/personality factors. Applied Cognitive Psychology 2011, 25:528-535.
52. Iaboni F., Douglas V.I., Ditto B. Psychophysiological response of ADHD children to reward and extinction. Psychophysiology 1997, 34:116-123.
53. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J.M., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Controlled Clinical Trials 1996, 17:1-12.
54. Jain R., Segal S., Kollins S.H., Khayrallah M. Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry 2011, 50(2):171-179.
55. Jasinski D.R., Krishnan S. Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse. Journal of Psychopharmacology 2009, 23:419-427.
56. Jensen P.S., Arnold L.E., Swanson J.M., Vitiello B., Abikoff H.B., Greenhill L.L., et al. Three-year follow-up of the NIMH MTA study. Journal of the American Academy of Child and Adolescent Psychiatry 2007, 46(8):989-1002.
57. Kay G.G., Michaels M.A., Pakull B. Simulated driving changes in young adults with ADHD receiving mixed amphetamine salts extended release and atomoxetine. Journal of Attention Disorders 2009, 12:316-329.
58. Kennard B.D., Stewart S.M., Olvera R., Bawdon R.E., O'Hailin A., Lewis C.P., et al. Nonadherence in adolescent oncology patients: Preliminary data on psychological risk factors and relationships to outcome. Journal of Clinical Psychology in Medical Settings 2004, 1:30-39.
59. Kent K.M., Pelham W.E., Molina B.S.G., Sibley M.H., Waschbusch D.A., Yu J., et al. The academic experience of male high school students with ADHD. Journal of Abnormal Child Psychology 2011, 39:451-462.
60. Kollins S.H., Jain R., Brams M., Segal S., Findling R.L., Wigal S.B., et al. Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD. Pediatrics 2011, 127:e1406-e1413.
61. Lacina J. Technology in the classroom: Virtual record keeping: should teachers keep online grade books?. Childhood Education 2006, 82:252-254.
62. Langberg J.M., Epstein J.N., Becker S.P., Girio-Herrera E., Vaughn A.J. Evaluation of the homework, organization, and planning skills (HOPS) intervention for middle school students with attention deficit hyperactivity disorder as implemented by school mental health providers. School Psychology Review 2012, 41:342.
63. McCarthy S., Asherson P., Coghill D., Hollis C., Murray M., Potts L., et al. Attention-deficit hyperactivity disorder: Treatment discontinuation in adolescents and young adults. The British Journal of Psychiatry 2009, 194:273-277.
64. Melby-Lervåg M., Hulme C. Is working memory training effective? A meta-analytic review. Developmental Psychology 2013, 49:270.
65. Meyer K., Kelley M.L. Improving homework in adolescents with attention-deficit/hyperactivity disorder: Self vs. parent monitoring of homework behavior and study skills. Child & Family Behavior Therapy 2007, 29:25-42.
66. Miller W.R., Rollnick S. Motivational interviewing: Helping people change 2013, Guilford Press, New York.
67. Moffitt T.E., Caspi A. Childhood predictors differentiate life-course persistent and adolescence-limited antisocial pathways among males and females. Development and Psychopathology 2001, 13:355-375.
68. Molina B., Hinshaw S., Swanson J., Arnold L., Vitiello B., Jensen P., et al. The MTA at 8years: Prospective follow-up of children treated for combined-type ADHD in a multisite study. Journal of the American Academy of Child and Adolescent Psychiatry 2009, 48:484-500.
69. Morris G.B. A rational-emotive treatment program with conduct disorder and attention-deficit hyperactivity disorder adolescents. Journal of Rational-Emotive & Cognitive-Behavior Therapy 1993, 11:123-134.
70. Morris S.B. Estimating effect sizes from pretest-posttest-control group designs. Organizational Research Methods 2008, 11:364-386.
71. MTA Cooperative Group 14-month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder. Archives of General Psychiatry 1999, 56:1073-1086.
72. Owens J.S., Johannes L.M., Karpenko V. The relation between change in symptoms and functioning in children with ADHD receiving school-based mental health services. School Mental Health 2009, 1:183-195.
73. Pelham W., Fabiano G. Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder. Journal of Clinical Child & Adolescent Psychology 2008, 37:184-214.
74. Pelham W.E., Fabiano G.A., Massetti G.M. Evidence-based assessment of attention deficit hyperactivity disorder in children and adolescents. Journal of Clinical Child and Adolescent Psychology 2005, 34:449-476.
75. Pelham W.E., Meichenbaum D., Smith B., Sibley M.H., Gnagy E., Bukstein O. The effect of MPH on parent-directed conflict behavior in adolescents with ADHD. Journal of Attention Disorders 2013.
76. Pelham W.E., Smith B.H., Evans S.W., Bukstein O., Gnagy E.M., Greiner A.R., et al. The effectiveness of short and long-acting stimulant medications for adolescents with ADHD in a naturalistic secondary school setting. Journal of Attention Disorders 2013.
77. Pliszka S., AACAP Work Group on Quality Issues Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2007, 46:894-921.
78. Rapport M.D., Orban S.A., Kofler M.J., Friedman L.M. Do programs designed to train working memory, other executive functions, and attention benefit children with ADHD? A meta-analytic review of cognitive, academic, and behavioral outcomes. Clinical Psychology Review 2013, 33:1237-1252.
79. Riggs P.D., Hall S.K., Mikulich-Gilbertson S.K., Lohman M., Kayser A. A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 2004, 43:420-429.
80. Riggs P.D., Winhusen T., Davies R.D., Leimberger J.D., Mikulich-Gilbertson S., Klein C., et al. Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders. Journal of the American Academy of Child and Adolescent Psychiatry 2011, 50:903-914.
81. Sallee F.R., Mcgough J., Wigal T., Donahue J., Lyne A., Biederman J., et al. Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: A placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry 2009, 48:155-165.
82. SAMHSA National registry for evidenced-based programs and practices. Substance Abuse and Mental Health Service Administration 2013, (Retrieved August 2013 from www.samhsa.org).
83. Schultz B., Evans S., Serpell Z. Preventing failure among middle school students with attention deficit hyperactivity disorder: A survival analysis. School Psychology Review 2009, 38:14-27.
84. Sibley M.H., Pelham W.E., Derefinko K.D., Kuriyan A.B., Sanchez F., Graziano P.A. A Pilot Trial of Supporting Teens' Academic Needs Daily (STAND): A parent- adolescent collaborative intervention for ADHD. Journal of Psychopathology and Behavioral Assessment 2013, 35:436-449.
85. Sibley M.H., Pelham W.E., Evans S.W., Gnagy E.M., Ross J.M., Greiner A.R. Evaluation of a summer treatment program for adolescents with Attention Deficit/Hyperactivity Disorder. Cognitive and Behavioral Practice 2011, 18:530-544.
86. Sibley M.H., Pelham W.E., Mazur A.N., Ross J.M., Biswas A. The effect of video-feedback on the social behavior of an adolescent with ADHD. Journal of Attention Disorders 2012, 16:579-588.
87. Sibley M.H., Pelham W.E., Molina B.S., Gnagy E.M., Waschbusch D.A., Biswas A., et al. The delinquency outcomes of boys with ADHD with and without comorbidity. Journal of Abnormal Child Psychology 2011, 39:21-32.
88. Sibley M.H., Pelham W.E., Molina B.S.G., Gnagy E.M., Waschbusch D.A., Garefino A., et al. Diagnosing ADHD in adolescence. Journal of Consulting and Clinical Psychology 2012, 80:139-150.
89. Sibley M.H., Smith B.H., Evans S.W., Pelham W.E., Gnagy E.M. Treatment response to an intensive adolescent-directed intervention for ADHD. Journal of Attention Disorders 2012, 16:443-448.
90. Sisk C.L., Foster D.L. The neural basis of puberty and adolescence. Nature Neuroscience 2004, 7:1040-1047.
91. Smith B., Waschbusch D., Willoughby M., Evans S. The efficacy, safety and practicality of treatments for adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD). Clinical Child and Family Psychology Review 2000, 3:243-267.
92. Sonuga-Barke E.J., Brandeis D., Cortese S., Daley D., Ferrin M., Holtmann M., et al. Nonpharmacological interventions for ADHD: Systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. American Journal of Psychiatry 2013, 170:275-289.
93. Spencer T.J., Biederman J., Ciccone P.E., Madras B.K., Dougherty D.D., Bonab A.A., et al. PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short-and long-acting oral methylphenidate. American Journal of Psychiatry 2006, 163:387-395.
94. Spencer T.J., Wilens T.E., Biederman J., Weisler R.H., Read S.C., Pratt R. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: A 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Clinical Therapeutics 2006, 28:266-279.
95. Stein B.D., Klein G.R., Greenhouse J.B., Kogan J.N. Treatment of attention-deficit hyperactivity disorder: Patterns of evolving care during the first treatment episode. Psychiatric Services 2012, 63:122-129.
96. Steinberg L., Fletcher A., Darling N. Parental monitoring and peer influences on adolescent substance use. Pediatrics 1994, 93:1060-1064.
97. Steiner N.J., Sheldrick R.C., Gotthelf D., Perrin E.C. Computer-based attention training in the schools for children with attention deficit/hyperactivity disorder: A preliminary trial. Clinical Pediatrics 2011, 50:615-622.
98. Thompson A.L., Molina B.S., Pelham W., Gnagy E.M. Risky driving in adolescents and young adults with childhood ADHD. Journal of Pediatric Psychology 2007, 32:745-759.
99. Thurstone C., Riggs P.D., Salomonsen-Sautel S., Mikulich-Gilbertson S.K. Randomized, controlled trial of atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2010, 49:573-582.
100. U.S.Department of Education What works clearinghouse 2013, Institute of Education Sciences, (Retrieved August 2013 from ies.ed.gov).
101. Valo S., Tannock R. Diagnostic instability of DSM-IV ADHD subtypes: Effects of informant source, instrumentation, and methods for combining symptom reports. Journal of Clinical Child & Adolescent Psychology 2010, 39:749-760.
102. Visser S.N., Danielson M.L., Bitsko R.H., Holbrook J.R., Kogan M.D., Ghandour R.M., Blumberg S.J. Trends in the Parent-Report of Health Care Provider-Diagnosed and Medicated Attention-Deficit/Hyperactivity Disorder: United States, 2003-2011. Journal of the American Academy of Child & Adolescent Psychiatry 2014, 53(1):34-46.
103. Waschbusch D.A., Pelham W.E., Waxmonsky J., Johnston C. Are there placebo effects in the medication treatment of children with attention-deficit hyperactivity disorder?. Journal of Developmental & Behavioral Pediatrics 2009, 30:158-168.
104. Waxmonsky J.G. Non-stimulant therapies for pediatric and adult ADHD. Essential Psychopharmacology 2005, 6:262-276.
105. Waxmonsky J., Waschbusch D., Babinski D., Humphrey H., Crum K., Alfonso A., et al. "Does Pharmacological Treatment of ADHD in Adults Enhance Parenting Performance?" at the 53rd Annual NCDEU Meeting, Hollywood, Fl 2013.
106. Waxmonsky J.G., Wilens T.E. Pharmacotherapy of adolescent substance use disorders: A review of the literature. Journal of Child & Adolescent Psychopharmacology 2005, 15:810-825.
107. Weiss M., Safren S.A., Solanto M.V., Hechtman L., Rostain A.L., Ramsay J., et al. Research forum on psychological treatment of adults with ADHD. Journal of Attention Disorders 2008, 11:642-651.
108. WHO Adolescent development 2013, World Health Organization, (Retrieved May 2013 from www.who.int).
109. Wilens T., Boellner S., Lopez F., Turnbow J., Wigal S., Childress A., et al. Varying the wear time of the methylphenidate transdermal system in children with Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2008, 47:700-708.
110. Wilens T.E., Bukstein O., Brams M., Cutler A.J., Childress A., Rugino T., et al. A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry 2012, 51:74-85.
111. Wilens T.E., McBurnett K., Bukstein O., McGough J., Greenhill L., Lerner M., et al. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with Attention-Deficit/Hyperactivity Disorder. Archives of Pediatrics & Adolescent Medicine 2006, 160:82.
112. Wilens T.E., Newcorn J.H., Kratochvil C.J., Gao H., Thomason C.K., Rogers A.K., et al. Long-term atomoxetine treatment in adolescents with Attention-Deficit/Hyperactivity Disorder. The Journal of Pediatrics 2006, 149:112-119.
113. Wolraich M.L., Greenhill L.L., Pelham W., Swanson J., Wilens T., Palumbo D., et al. Randomized, controlled trial of OROS methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics 2001, 108:883-892.